DE10118452A1 - Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse - Google Patents

Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse

Info

Publication number
DE10118452A1
DE10118452A1 DE10118452A DE10118452A DE10118452A1 DE 10118452 A1 DE10118452 A1 DE 10118452A1 DE 10118452 A DE10118452 A DE 10118452A DE 10118452 A DE10118452 A DE 10118452A DE 10118452 A1 DE10118452 A1 DE 10118452A1
Authority
DE
Germany
Prior art keywords
nucleic acid
thyroid
seq
tumors
hyperplasia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10118452A
Other languages
German (de)
English (en)
Inventor
Joern Bullerdiek
Volkhard Rippe
Maren Meiboom
Gazanfer Belge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Bremen 28359 Bremen De
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE10118452A priority Critical patent/DE10118452A1/de
Priority to PCT/EP2002/004090 priority patent/WO2002083727A2/de
Priority to AU2002310840A priority patent/AU2002310840A1/en
Priority to EP02735249A priority patent/EP1377607A2/de
Priority to JP2002581482A priority patent/JP2005503123A/ja
Publication of DE10118452A1 publication Critical patent/DE10118452A1/de
Priority to US10/684,042 priority patent/US20050095594A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE10118452A 2001-04-12 2001-04-12 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Withdrawn DE10118452A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE10118452A DE10118452A1 (de) 2001-04-12 2001-04-12 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse
PCT/EP2002/004090 WO2002083727A2 (de) 2001-04-12 2002-04-12 Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
AU2002310840A AU2002310840A1 (en) 2001-04-12 2002-04-12 Nucleic acid sequences of hyperplasies and tumors of the thyroid
EP02735249A EP1377607A2 (de) 2001-04-12 2002-04-12 Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
JP2002581482A JP2005503123A (ja) 2001-04-12 2002-04-12 甲状腺の過形成と腫瘍の核酸配列
US10/684,042 US20050095594A1 (en) 2001-04-12 2003-10-10 Nucleic acid sequences of hyperplasies and tumors of the thyroid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10118452A DE10118452A1 (de) 2001-04-12 2001-04-12 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse

Publications (1)

Publication Number Publication Date
DE10118452A1 true DE10118452A1 (de) 2002-10-31

Family

ID=7681480

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10118452A Withdrawn DE10118452A1 (de) 2001-04-12 2001-04-12 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse

Country Status (5)

Country Link
EP (1) EP1377607A2 (enrdf_load_stackoverflow)
JP (1) JP2005503123A (enrdf_load_stackoverflow)
AU (1) AU2002310840A1 (enrdf_load_stackoverflow)
DE (1) DE10118452A1 (enrdf_load_stackoverflow)
WO (1) WO2002083727A2 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005011003B4 (de) * 2004-03-03 2008-07-31 Universität Leipzig Verfahren und Mittel zur differentiellen Diagnose von Schilddrüsentumoren

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG161311A1 (en) * 2005-05-04 2010-05-27 Noxxon Pharma Ag Novel use of spiegelmers
US8828656B2 (en) 2009-08-31 2014-09-09 University Of Bremen Microrna-based methods and compositions for the diagnosis, prognosis and treatment of tumor involving chromosomal rearrangements
US10404099B1 (en) 2018-02-28 2019-09-03 Corning Optical Communications LLC Intermediate power supply unit for distributing lower voltage power to remote power distribution systems

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033982A2 (en) * 1997-12-23 1999-07-08 Chiron Corporation Human genes and gene expression products i

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005011003B4 (de) * 2004-03-03 2008-07-31 Universität Leipzig Verfahren und Mittel zur differentiellen Diagnose von Schilddrüsentumoren
DE102005011003B9 (de) * 2004-03-03 2009-02-26 Universität Leipzig Verfahren und Mittel zur differentiellen Diagnose von Schilddrüsentumoren

Also Published As

Publication number Publication date
JP2005503123A (ja) 2005-02-03
AU2002310840A1 (en) 2002-10-28
EP1377607A2 (de) 2004-01-07
WO2002083727A3 (de) 2003-04-17
WO2002083727A2 (de) 2002-10-24

Similar Documents

Publication Publication Date Title
DE69633664T2 (de) Genetische marker für brust und eierstockkrebs
DE69521002T3 (de) Mutationen des mit 17q verbundenen Ovarial- und Brustkrebs Empfindlichkeitsgens
EP1027440B2 (de) Inhibitor-protein des wnt-signalwegs
DE69519834T3 (de) Verfahren zum Nachweis von Prädisposition von Ovarial- und Brustkrebs
DE69625678T2 (de) Chromosom 13 verbundene Brustkrebsempfindlichkeitsgen BRCA2
DE69631540T2 (de) Materialien und methoden mit bezug zur identifizierung und sequenzierung des krebs-suszeptilitaetsgens brca2 und dessen anwendungen
DE69433940T2 (de) Menschliches mutator-gen nmsh2 und seine verbindung zum hereditaren, nichtpolypösen kolorrektalen karzinom
DE69633272T2 (de) Methoden zur Krebsbehandlung und -kontrolle
DE60214867T2 (de) Histonedeacetylase 9
DE69424209T2 (de) Tumorsuppressor-Gen Merlin und dessen Verwendungen
EP0870024A2 (de) Nukleinsäuresequenzen von genen der high mobility group proteine sowie verwendungen derselben
WO1999007855A1 (de) Neutrale sphingomyelinase
DE69631041T2 (de) Promotor des utrophingens
DE10118452A1 (de) Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse
EP1220921B1 (de) Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
DE69936781T2 (de) Kvlqt1 - im zusammenhang mit 'long qt syndrom'
EP1237910B1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
DE10009119A1 (de) Vertebraten Globin
DE69434333T2 (de) Methoden unter verwendung von eaa3 oder eaa4 rezeptoren
WO1999053091A2 (de) Gdnf-kodierende dna, teile davon und gdnf-varianten
DE19817118C1 (de) Dyskerin und dafür codierende DNA-Moleküle, diese enthaltende Vektoren, Antikörper gegen Dyskerin und die Verwendung dieser Gegenstände
DE10001377A1 (de) bHLH-Transkriptionsfaktor ASCL3 und diesen enthaltendes Arzneimittel
WO2003093310A1 (de) Neue nukleinsäuresequenzen und proteine von tumoren und neoplasien der schilddrüse
DE69928960T2 (de) Herstellung eines retrovirus, welches den mel-lokus von streptomyces enthält, sowie dessen expression in säugetierzellen
EP0939813A1 (de) Mammakarzinom-assoziiertes gen

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: UNIVERSITAET BREMEN, 28359 BREMEN, DE

8110 Request for examination paragraph 44
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20111101